Abstract
Purpose
This study evaluates the role and outcomes of Gamma Knife radiosurgery (GKRS) in the management of pituitary metastases.
Methods
The records of brain metastases patients who underwent GKRS at the University of Pittsburgh Medical Center during the 10-year interval of 2010–2020 were systematically reviewed. Outcome measures included patient survival, tumor control rate, pituitary hormonal outcomes, visual outcomes, adverse radiation effects (AREs), and need for adjuvant therapy.
Results
Eighteen patients with pituitary metastases (eight male; median age of 65.5 years) had sufficient clinical follow-up for analysis. The most common primary cancers were non-small cell lung cancer (n = 6) and breast cancer (n = 4). Patients presented with headache (n = 9) and visual difficulties (n = 6). One patient underwent resection before GKRS. The median tumor volume was 0.78 cc (range 0.04–6.42 cc). The median overall survival after GKRS was 6.5 months (range 0.5–58 months). The overall survival after GKRS at 3-, 6-, and 12-months were 72.2%, 50.0% and 38.9%, respectively. The tumor control rate was 94.4%. One patient had further progression that required additional GKRS. None of the patients developed AREs after GKRS.
Conclusion
GKRS is an effective treatment modality for the multidisciplinary management of patients with pituitary metastases. This minimally-invasive strategy is associated with optimal tumor control rate and low risk to adjacent optic nerves or neurovascular structures.
Similar content being viewed by others
Data availability
All authors confirm the appropriateness of all dataset and software used for supporting the conclusion.
Code availability
Not applicable.
References
McCormick PC et al (1989) Metastatic carcinoma to the pituitary gland. Br J Neurosurg 3(1):71–79
Sioutos P, Yen V, Arbit E (1996) Pituitary gland metastases. Ann Surg Oncol 3(1):94–99
Fassett DR, Couldwell WT (2004) Metastases to the pituitary gland. Neurosurg Focus 16(4):E8
Kano H et al (2009) Stereotactic radiosurgery for pituitary metastases. Surg Neurol 72(3):248–55
Ng S et al (2020) Current status and treatment modalities in metastases to the pituitary: a systematic review. J Neurooncol 146(2):219–227
Habu M et al (2015) Pituitary metastases: current practice in Japan. J Neurosurg 123(4):998–1007
Chon H et al (2017) Hypofractionated stereotactic radiosurgery for pituitary metastases. J Neurooncol 132(1):127–133
He W et al (2015) Metastatic involvement of the pituitary gland: a systematic review with pooled individual patient data analysis. Pituitary 18(1):159–168
Max MB, Deck MD, Rottenberg DA (1981) Pituitary metastasis: incidence in cancer patients and clinical differentiation from pituitary adenoma. Neurology 31(8):998–1002
Abou-Al-Shaar H, Faramand A, Zhang X, Mallela AN, Branstetter BF, Wiley CA, Lunsford LD (2021) Chronic encapsulated expanding hematomas after stereotactic radiosurgery for intracranial arteriovenous malformations. J Neurosurg 136(2):492–502
Faramand A et al (2019) Primary or salvage stereotactic radiosurgery for brain metastatic small cell lung cancer. J Neurooncol 144(1):217–225
Wei Z et al (2022) A volume matched comparison of survival after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases. J Neurooncol 157(3):417–423
Kano H et al (2010) T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery. Neurosurgery 66(3):486–91
Duchen LW (1966) Metastatic carcinoma in the pituitary gland and hypothalamus. J Pathol Bacteriol 91(2):347–355
Gsponer J et al (1999) Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses: retrospective analysis of 353 patients. Medicine (Baltimore) 78(4):236–69
Teears RJ, Silverman EM (1975) Clinicopathologic review of 88 cases of carcinoma metastatic to the putuitary gland. Cancer 36(1):216–220
Schill F et al (2019) Pituitary metastases: a nationwide study on current characteristics with special reference to breast cancer. J Clin Endocrinol Metab 104(8):3379–3388
Al-Aridi R et al (2014) Clinical and biochemical characteristic features of metastatic cancer to the sella turcica: an analytical review. Pituitary 17(6):575–587
Shimon I (2020) Metastatic Spread to the Pituitary. Neuroendocrinology 110(9–10):805–808
Lin CY et al (2015) Prognostic factors in cancer patients with symptomatic pituitary metastasis: a clinical case study. Anticancer Res 35(2):983–987
Javanbakht A et al (2018) Pituitary metastasis: a rare condition. Endocr Connect 7:1049–1057
Iwai Y et al (2004) Radiosurgery for pituitary metastases. Neurol Med Chir (Tokyo) 44(3):112–116
Benjamin C et al (2020) Treatment of sellar metastases with gamma knife radiosurgery in patients with advanced cancer. Pituitary 23(6):665–671
Zoli M et al (2013) Pituitary metastases: role of surgery. World Neurosurg 79(2):327–330
Burkhardt T et al (2016) Surgical management of pituitary metastases. Pituitary 19(1):11–18
Acknowledgements
None
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
HAAS and LDL designed the study. Material preparation, data collection and analysis were performed by ZW and SY. The first draft of the manuscript was written by ZW and all authors critically revised previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Dr. Lunsford is a consultant for Insightec DSMB and has direct stock ownership in Elekta AB. All other authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
Ethical approval
The study was approved by the IRB at the University of Pittsburgh Medical Center.
Research involving human participants and/or animals
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Ethical Committee at the University of Pittsburgh Medical Center.
Consent to participate
Informed consent was obtained from all participants included in study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wei, Z., Yavan, S., Deng, H. et al. The role of stereotactic radiosurgery in the multidisciplinary management of pituitary metastases. Pituitary 25, 948–958 (2022). https://doi.org/10.1007/s11102-022-01279-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-022-01279-z